Do not use for diagnosis of Epstein-Barr virus infectious mononucleosis. May aid in the detection and prognosis of nasopharyngeal carcinoma.
Enzyme-Linked Immunosorbent Assay/Semi-Quantitative Chemiluminescent Immunoassay
Serum Separator Tube (SST).
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.
Contaminated, heat-inactivated, or grossly hemolyzed specimens.
Label specimens plainly as acute or convalescent.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (Avoid repeated freeze/thaw cycles).
|0050235||Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgG||Effective February 19, 2013
17.9 U/mL or less: Not Detected
18.0-21.9 U/mL: Indeterminate. Repeat testing in 10-14 days may be helpful.
22.0 U/mL or greater: Detected
|0051626||Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgA||Effective February 19, 2013
0.79 U/mL or less: Not Detected
0.80 - 1.20 U/mL: Indeterminate. Repeat testing in 10-14 days may be helpful.
1.21 U/mL or greater: Detected
Compliance Statement D: For laboratory tests using a manufactured RUO kit. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
|Component Test Code*||Component Chart Name||LOINC|
|0050235||EBV Antibody to Viral Capsid Antigen IgG||7885-7|
|0051626||EBV Antibody To Viral Capsid Antigen IgA||31369-2|
- EBV and VCA Ab
- EBV Antibodies
- EBV VCA- Ab
- Infectious Mononucleosis